FindTrial
Sign In

Escitalopram (Lexapro)

DRUG6 trials

Sponsors

The University of New South Wales, University of Rochester, National Health Research Institutes, Taiwan, Seoul National University Hospital, Gang Wang

Conditions

Alzheimer's DiseaseBipolar DisordersDepressionDepression - Major Depressive DisorderMajor Depressive Disorder (MDD)Postpartum DepressionPosttraumatic Stress DisorderPsychomotor Agitation

Phase 2

Escitalopram as a Mood Stabilizer for Bipolar II Disorder
CompletedNCT00156325
The University of New South WalesBipolar Disorders
Start: 2004-02-29End: 2005-02-28Target: 10Updated: 2006-01-02
Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
NCT01008098
Seoul National University HospitalPosttraumatic Stress Disorder
Start: 2008-11-30End: 2014-02-28Target: 26Updated: 2012-06-07

Phase 4

Escitalopram Treatment of Patients With Agitated Dementia
CompletedNCT00260624
University of RochesterAlzheimer's Disease, Psychomotor Agitation
Start: 2003-02-28End: 2006-12-31Target: 20Updated: 2012-02-24

Unknown Phase

Lexapro in the Treatment of Patients With Postpartum Depression
CompletedNCT00277108
University of RochesterPostpartum Depression
Start: 2004-02-29End: 2007-04-30Target: 20Updated: 2008-11-06
Clinical Pharmacogenomics of Antidepressant Response
CompletedNCT00384020
National Health Research Institutes, TaiwanDepression
Start: 2006-01-31End: 2010-01-31Updated: 2010-02-01
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
RecruitingNCT06692361
Gang WangDepression - Major Depressive Disorder, Major Depressive Disorder (MDD)
Start: 2025-01-01End: 2026-12-31Target: 214Updated: 2025-12-02